Trials / Completed
CompletedNCT04198298
Prospective Clinical Trial of Three Apical Sealing Materials
Prospective Comparative Randomized Clinical Trial of Three Endodontic Retrograde Filling Materials
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- University of the Pacific · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This prospective comparative randomized clinical trial compares healing and bony regeneration in patients who received 1 of 3 different retrograde filling materials following microsurgical apicoectomies for the treatment of periapical lesions of endodontic origin.
Detailed description
A prospective comparative randomized clinical trial was designed to evaluate the healing and bony regeneration in patients who received 1 of 3 different retrograde filling materials (EndoSequence®, ProRoot® MTA, or Biodentine®) following microsurgical apicoectomies for the treatment of periapical lesions of endodontic origin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EndoSequence | The EndoSequence® retrograde sealing material was used to provide a biologic seal at the apex. |
| DRUG | ProRoot MTA | The ProRoot® MTA retrograde sealing material was used to provide a biologic seal at the apex. |
| DRUG | Biodentine | The Biodentine® retrograde sealing material was used to provide a biologic seal at the apex. |
Timeline
- Start date
- 2014-11-02
- Primary completion
- 2017-05-31
- Completion
- 2017-05-31
- First posted
- 2019-12-13
- Last updated
- 2019-12-13
Source: ClinicalTrials.gov record NCT04198298. Inclusion in this directory is not an endorsement.